Document is current
Any future updates will be listed below
-
Authors
Kolb, Hubert
Kempf, Kerstin
Röhling, Martin
Lenzen-Schulte, Martina
Schloot, Nanette C.
Martin, Stephan
- License Information
-
More Information
Article History
Received: 27 August 2021
Accepted: 9 November 2021
First Online: 9 December 2021
Declarations
:
: Not applicable.
: Not applicable.
: S. Martin has received non-restricted support for the conduct of trials of lifestyle change in persons at risk or with type 2 diabetes from Novartis Pharma GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Almased Wellness GmbH, Nintendo of Europe GmbH, HMM Holding AG, and Gesellschaft von Freunden und Förderern der Heinrich-Heine-Universität Düsseldorf e.V. H. Kolb, K. Kempf, M. Röhling, and M. Lenzen-Schulte have nothing to disclose. N. C. Schloot is currently employed by Lilly Germany and a stockholder of Lilly.
